A new regimen of amsacrine with high-dose cytarabine is safe and effective therapy for acute leukemia.
暂无分享,去创建一个
T. Ahmed | E. Feldman | A. Mittelman | Z. Arlin | R. Mehta | P. Baskind | P. Weinstein | P. Sullivan | E. Rieber
[1] R. Willemze,et al. Amsacrine with high-dose cytarabine in acute leukemia. , 1985, Cancer treatment reports.
[2] T. Ahmed,et al. Treatment of acute leukemia with amsacrine and high-dose cytarabine. , 1985, Cancer treatment reports.
[3] R. Warrell,et al. Homoharringtonine: an effective new drug for remission induction in refractory nonlymphoblastic leukemia. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] J. Desforges,et al. Cytosine-arabinoside-induced colitis and peritonitis: nonoperative management. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] R. Silver,et al. Phase I-II trial of mitoxantrone in acute leukemia. , 1985, Cancer treatment reports.
[6] J. Glick,et al. High-dose cytosine arabinoside and m-AMSA is effective therapy in relapsed acute nonlymphocytic leukemia. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] Arlin Za. Current status of amsacrine (AMSA) combination chemotherapy programs in acute leukemia. , 1983 .
[8] H. Lazarus,et al. High-dose cytosine arabinoside therapy for refractory leukemia. , 1983, Blood.
[9] G. Browman,et al. Therapy of secondary acute nonlymphocytic leukemia with cytarabine. , 1983, The New England journal of medicine.
[10] E. Freireich,et al. Evaluation of AMSA in previously treated patients with acute leukemia: results of therapy in 109 adults. , 1982, Blood.
[11] U. Roessmann,et al. Central nervous system toxicity of high‐dose systemic cytosine arabinoside , 1981, Cancer.
[12] R. Mertelsmann,et al. Treatment of acute leukemia in relapse with 4'(9-acridinylamino) methanesulfon-m-anisidide (AMSA) in combination with cytosine arabinoside and thioguanine. , 1981, Cancer clinical trials.
[13] B. Clarkson,et al. Phase I and II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide in patients with acute leukemia. , 1980, Cancer research.
[14] J. Bertino,et al. High dose cytosine arabinoside (HDARAC) in refractory acute leukemia , 1979, Cancer.